BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials.
Last month in BMC Cancer
Support and Guidance
How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.
Featured video: Microparticles, breast cancer's secret weapon?
The Editors of BMC Cancer and BMC Medicine invite of submissions to our ‘Targeted Therapy’ cross journal collection. Guest edited by Prof. Min Li (University of Oklahoma Health Sciences Center, USA) and Dr. Yanis Boumber (The Northwestern University, USA).
We advise to submit by 1st August 2021 if you would like your manuscript to be ready for the launch date.
The Editors of BMC Cancer, BMC Microbiology and Microbiome invite of submissions to our ‘Microbiome and Cancer’ cross journal collection. Guest edited by Prof. Christopher Staley, Dr. Jacques Ravel and Dr. Sean Devlin.
Open for submissions until 30th September 2021.
BMC Series Focus Issues
In celebration of World Environment Day on the 5th June, the BMC Series presents a focus issue on Water and Sanitation. We have collated open-access content from across our journals to highlight research into clean water, investigating links between water and health and our overall relationship with water.
With Mental Health Awareness Month in May, the BMC Series presents a focus issue on ‘Understanding Mental Health’. We have brought together content to highlight research into understanding and improving mental health.
Click here to view which Articles have been shared most in the last 6 months!
BMC Series Blog
Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...
Annual Journal Metrics
79 days to first decision for reviewed manuscripts only
55 days to first decision for all manuscripts
170 days from submission to acceptance
16 days from acceptance to publication
3.15 - 2-year Impact Factor
3.432 - 5-year Impact Factor
1.021 - Source Normalized Impact per Paper (SNIP)
1.186 - SCImago Journal Rank (SJR)
2,117 Altmetric Mentions